{"id":114889,"date":"2022-04-12T21:47:23","date_gmt":"2022-04-12T21:47:23","guid":{"rendered":"https:\/\/stg.stg.harmonyadjuvantmelanomastudy.com\/vragen-over-de-studiebehandeling\/"},"modified":"2023-02-13T19:17:39","modified_gmt":"2023-02-13T19:17:39","slug":"vragen-over-de-studiebehandeling","status":"publish","type":"page","link":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/vragen-over-de-studiebehandeling\/","title":{"rendered":"Vragen over de studiebehandeling"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=&#8221;90&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;5&#8243; bottom_padding=&#8221;5&#8243; back_color=&#8221;color-105898&#8243; back_image=&#8221;110855&#8243; back_position=&#8221;center top&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; top_divider=&#8221;gradient&#8221; bottom_divider=&#8221;step_3_4&#8243; uncode_shortcode_id=&#8221;171042&#8243; back_color_type=&#8221;uncode-palette&#8221; back_color_solid=&#8221;#ff0000&#8243; overlay_color_type=&#8221;uncode-palette&#8221; overlay_color_solid=&#8221;#ff0000&#8243; border_color_type=&#8221;uncode-palette&#8221; border_color_solid=&#8221;#ff0000&#8243;][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; gutter_size=&#8221;6&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;744311&#8243;][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; inverted_device_order=&#8221;yes&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; gutter_size=&#8221;2&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;4&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; width=&#8221;7\/12&#8243; uncode_shortcode_id=&#8221;128842&#8243;][vc_custom_heading heading_semantic=&#8221;h1&#8243; text_font=&#8221;font-146862&#8243; text_size=&#8221;fontsize-338686&#8243; text_weight=&#8221;400&#8243; text_height=&#8221;fontheight-179065&#8243; text_space=&#8221;fontspace-781688&#8243; uncode_shortcode_id=&#8221;302619&#8243;]VEELGESTELDE VRAGEN[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; text_weight=&#8221;400&#8243; text_height=&#8221;fontheight-357766&#8243; uncode_shortcode_id=&#8221;865545&#8243;]Vragen over de studiebehandeling[\/vc_custom_heading][vc_empty_space empty_h=&#8221;1&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;4&#8243; mobile_width=&#8221;0&#8243; width=&#8221;5\/12&#8243; uncode_shortcode_id=&#8221;872545&#8243;][vc_single_image media=&#8221;110851&#8243; media_width_percent=&#8221;100&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;192190&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;4&#8243; bottom_padding=&#8221;4&#8243; overlay_alpha=&#8221;100&#8243; gutter_size=&#8221;100&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; style=&#8221;inherited&#8221;][vc_column column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; zoom_width=&#8221;0&#8243; zoom_height=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;790384&#8243;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; text_space=&#8221;fontspace-781688&#8243; uncode_shortcode_id=&#8221;352457&#8243;]Vragen over de studiebehandeling[\/vc_custom_heading][vc_accordion typography=&#8221;yes&#8221; sign=&#8221;plus&#8221; active_tab=&#8221;0&#8243;][vc_accordion_tab gutter_size=&#8221;2&#8243; column_padding=&#8221;2&#8243; title=&#8221;Welke studiebehandeling zal ik krijgen tijdens de studie?&#8221; tab_id=&#8221;24a731b5-e185-3&#8243;][vc_column_text uncode_shortcode_id=&#8221;165891&#8243; text_color_type=&#8221;uncode-palette&#8221; text_color_solid=&#8221;#ff0000&#8243; border_color_type=&#8221;uncode-palette&#8221; border_color_solid=&#8221;#ff0000&#8243;]U wordt bij toeval in een behandelingsgroep geplaatst om de twee studiegeneesmiddelen te ontvangen (groep met lage dosis of groep met hoge dosis) of een behandelingsoptie genaamd pembrolizumab, die algemeen wordt gebruikt om te voorkomen dat melanoom terugkeert na een operatie voor het verwijderen van de kanker, samen met een placebo.[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab gutter_size=&#8221;2&#8243; column_padding=&#8221;2&#8243; title=&#8221;Wat wordt bedoeld met een \u2018studiegeneesmiddel\u2019?&#8221; tab_id=&#8221;1666717276638-7-7&#8243;][vc_column_text uncode_shortcode_id=&#8221;115688&#8243; text_color_type=&#8221;uncode-palette&#8221; text_color_solid=&#8221;#ff0000&#8243; border_color_type=&#8221;uncode-palette&#8221; border_color_solid=&#8221;#ff0000&#8243;]Met \u2018studiegeneesmiddel\u2019 bedoelt men dat de veiligheid en doeltreffendheid van de studiegeneesmiddelen nog niet volledig zijn beoordeeld en dat ze momenteel niet door landspecifieke regelgevende gezondheidsautoriteiten zijn goedgekeurd om te worden gebruikt voor de behandeling van een specifieke ziekte, maar dat het gebruik ervan wel is toegestaan voor klinisch onderzoek.[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab gutter_size=&#8221;2&#8243; column_padding=&#8221;2&#8243; title=&#8221;Hoe werken de studiegeneesmiddelen?&#8221; tab_id=&#8221;51669b3a-8e8e-2&#8243;][vc_column_text uncode_shortcode_id=&#8221;204986&#8243; text_color_type=&#8221;uncode-palette&#8221; text_color_solid=&#8221;#ff0000&#8243; border_color_type=&#8221;uncode-palette&#8221; border_color_solid=&#8221;#ff0000&#8243;]De studiegeneesmiddelen helpen uw immuuncellen kankercellen te vinden en te vernietigen.[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab gutter_size=&#8221;2&#8243; column_padding=&#8221;2&#8243; title=&#8221;Wordt een van de studiegeneesmiddelen al gebruikt voor de behandeling van gevorderd melanoom?&#8221; tab_id=&#8221;ef5915c9-1af0-2&#8243;][vc_column_text uncode_shortcode_id=&#8221;152079&#8243; text_color_type=&#8221;uncode-palette&#8221; text_color_solid=&#8221;#ff0000&#8243; border_color_type=&#8221;uncode-palette&#8221; border_color_solid=&#8221;#ff0000&#8243;]Pembrolizumab is in sommige landen goedgekeurd als behandelingsoptie voor melanoom bij volwassenen. Een van de andere studiegeneesmiddelen is in sommige landen goedgekeurd als behandelingsoptie bij andere soorten kanker, maar is momenteel niet goedgekeurd voor melanoom. Het derde studiegeneesmiddel is in geen enkel land goedgekeurd voor gelijk welke behandeling.[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab gutter_size=&#8221;2&#8243; column_padding=&#8221;2&#8243; title=&#8221;Wat is een placebo?&#8221; tab_id=&#8221;0a882431-6c4b-0&#8243;][vc_column_text uncode_shortcode_id=&#8221;188105&#8243; text_color_type=&#8221;uncode-palette&#8221; text_color_solid=&#8221;#ff0000&#8243; border_color_type=&#8221;uncode-palette&#8221; border_color_solid=&#8221;#ff0000&#8243;]Een placebo ziet er hetzelfde uit als het studiegeneesmiddel maar er zit geen actief geneesmiddel in. Zo hebben onderzoekers iets om het studiegeneesmiddel mee te vergelijken om de effecten ervan beter begrijpen. Niemand in de studie krijgt alleen placebo. Iedereen krijgt een actieve antikankerbehandeling.[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab gutter_size=&#8221;2&#8243; column_padding=&#8221;2&#8243; title=&#8221;Hoe worden de studiebehandelingsgroepen toegewezen?&#8221; tab_id=&#8221;1659029436671-5-0&#8243;][vc_column_text uncode_shortcode_id=&#8221;211551&#8243; text_color_type=&#8221;uncode-palette&#8221; text_color_solid=&#8221;#ff0000&#8243; border_color_type=&#8221;uncode-palette&#8221; border_color_solid=&#8221;#ff0000&#8243;]Een computer wordt gebruikt om deelnemers bij toeval aan studiebehandelingsgroepen toe te wijzen, zoals bij het delen uit een geschud pak kaarten. Dit wordt randomisatie genoemd.[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab gutter_size=&#8221;2&#8243; column_padding=&#8221;2&#8243; title=&#8221;Zijn er bijwerkingen van de studiegeneesmiddelen?&#8221; tab_id=&#8221;1659029463838-6-5&#8243;][vc_column_text uncode_shortcode_id=&#8221;143517&#8243; text_color_type=&#8221;uncode-palette&#8221; text_color_solid=&#8221;#ff0000&#8243; border_color_type=&#8221;uncode-palette&#8221; border_color_solid=&#8221;#ff0000&#8243;]Zoals bij alle geneesmiddelen bestaat er een kans op bijwerkingen. Dit zijn ongewenste en onbedoelde effecten van een geneesmiddel. Praat met de studiearts voor meer informatie over mogelijke bijwerkingen. Uw gezondheid zal gedurende de hele studie nauwlettend in de gaten gehouden worden. Het is heel belangrijk om de studiearts op de hoogte te stellen als u veranderingen in uw gezondheid opmerkt of als u ergens last van heeft.[\/vc_column_text][\/vc_accordion_tab][\/vc_accordion][vc_empty_space empty_h=&#8221;3&#8243;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; text_space=&#8221;fontspace-781688&#8243; uncode_shortcode_id=&#8221;859334&#8243;]Algemene studievragen[\/vc_custom_heading][vc_accordion typography=&#8221;yes&#8221; sign=&#8221;plus&#8221; active_tab=&#8221;0&#8243;][vc_accordion_tab gutter_size=&#8221;2&#8243; column_padding=&#8221;2&#8243; title=&#8221;Hoelang zal mijn deelname aan de studie duren?&#8221; tab_id=&#8221;1666716724-1-95&#8243;][vc_column_text uncode_shortcode_id=&#8221;378920&#8243; text_color_type=&#8221;uncode-palette&#8221; text_color_solid=&#8221;#ff0000&#8243; border_color_type=&#8221;uncode-palette&#8221; border_color_solid=&#8221;#ff0000&#8243;]U kunt maximaal 5 jaar aan de studie deelnemen.[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab gutter_size=&#8221;2&#8243; column_padding=&#8221;2&#8243; title=&#8221;Hoe vaak moet ik naar het studiecentrum gaan?&#8221; tab_id=&#8221;1666716724-2-33&#8243;][vc_column_text uncode_shortcode_id=&#8221;172396&#8243; text_color_type=&#8221;uncode-palette&#8221; text_color_solid=&#8221;#ff0000&#8243; border_color_type=&#8221;uncode-palette&#8221; border_color_solid=&#8221;#ff0000&#8243;]U legt gedurende 12 maanden ongeveer elke 3 weken studiebezoeken af om de studiebehandeling te krijgen en u ondergaat tests om ervoor te zorgen dat de behandeling veilig kan worden voortgezet. Ongeveer om de 12 weken ondergaat u ook scans voor toezicht. Hoe vaak u naar het studiecentrum komt, hangt na uw laatste dosis studiebehandeling af van uw tumorstatus.[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab gutter_size=&#8221;2&#8243; column_padding=&#8221;2&#8243; title=&#8221;Wat zijn de voordelen van deelname aan de klinische studie?&#8221; tab_id=&#8221;1666716837187-2-3&#8243;][vc_column_text uncode_shortcode_id=&#8221;368788&#8243; text_color_type=&#8221;uncode-palette&#8221; text_color_solid=&#8221;#ff0000&#8243; border_color_type=&#8221;uncode-palette&#8221; border_color_solid=&#8221;#ff0000&#8243;]U kunt al dan niet rechtstreeks voordeel hebben bij deelname aan deze klinische studie. U wordt echter voortdurend gecontroleerd door artsen die gespecialiseerd zijn in melanoomhuidkanker, en alle informatie die tijdens deze studie wordt verzameld, kan artsen helpen meer te weten te komen over de behandeling van anderen met melanoom.[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab gutter_size=&#8221;2&#8243; column_padding=&#8221;2&#8243; title=&#8221;Zal mijn deelname aan de studie kosten met zich meebrengen voor mij?&#8221; tab_id=&#8221;1666716838989-3-9&#8243;][vc_column_text uncode_shortcode_id=&#8221;148623&#8243; text_color_type=&#8221;uncode-palette&#8221; text_color_solid=&#8221;#ff0000&#8243; border_color_type=&#8221;uncode-palette&#8221; border_color_solid=&#8221;#ff0000&#8243;]Er zijn voor u geen kosten verbonden aan de studiegeneesmiddelen, bezoeken, tests of benodigdheden die nodig zijn voor de studie.[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab gutter_size=&#8221;2&#8243; column_padding=&#8221;2&#8243; title=&#8221;Wie sponsort de studie?&#8221; tab_id=&#8221;1666716840438-4-8&#8243;][vc_column_text uncode_shortcode_id=&#8221;114846&#8243; text_color_type=&#8221;uncode-palette&#8221; text_color_solid=&#8221;#ff0000&#8243; border_color_type=&#8221;uncode-palette&#8221; border_color_solid=&#8221;#ff0000&#8243;]Het biotechnologische bedrijf Regeneron Pharmaceuticals sponsort de Harmony-Adjuvant-studie. Het betaalt de studiearts en het studiecentrum om deze studie uit te voeren.[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab gutter_size=&#8221;2&#8243; column_padding=&#8221;2&#8243; title=&#8221;Wat als ik besluit om aan de studie mee te doen en dan van gedachten verander?&#8221; tab_id=&#8221;1666716966938-5-6&#8243;][vc_column_text uncode_shortcode_id=&#8221;133429&#8243; text_color_type=&#8221;uncode-palette&#8221; text_color_solid=&#8221;#ff0000&#8243; border_color_type=&#8221;uncode-palette&#8221; border_color_solid=&#8221;#ff0000&#8243;]Deelname aan de studie is geheel vrijwillig. Als u beslist om deel te nemen maar later van gedachten verandert, kunt u de studie op elk moment verlaten.[\/vc_column_text][\/vc_accordion_tab][\/vc_accordion][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row row_height_percent=&#8221;90&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;5&#8243; bottom_padding=&#8221;5&#8243; back_color=&#8221;color-105898&#8243; back_image=&#8221;110855&#8243; back_position=&#8221;center top&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; top_divider=&#8221;gradient&#8221; bottom_divider=&#8221;step_3_4&#8243; uncode_shortcode_id=&#8221;171042&#8243; back_color_type=&#8221;uncode-palette&#8221; back_color_solid=&#8221;#ff0000&#8243; [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-114889","page","type-page","status-publish","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.8 - aioseo.com -->\n\t<meta name=\"description\" content=\"De Harmony-Adjuvant-studie: VEELGESTELDE VRAGEN\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/vragen-over-de-studiebehandeling\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.8\" \/>\n\t\t<meta property=\"og:locale\" content=\"nl_NL\" \/>\n\t\t<meta property=\"og:site_name\" content=\"The Harmony-Adjuvant Study - Skin Cancer - Preventing Melanoma From Returning After Surgery\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"The Harmony-Adjuvant Study Vragen over de studiebehandeling\" \/>\n\t\t<meta property=\"og:description\" content=\"De Harmony-Adjuvant-studie: VEELGESTELDE VRAGEN\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/vragen-over-de-studiebehandeling\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2022-04-12T21:47:23+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2023-02-13T19:17:39+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"The Harmony-Adjuvant Study Vragen over de studiebehandeling\" \/>\n\t\t<meta name=\"twitter:description\" content=\"De Harmony-Adjuvant-studie: VEELGESTELDE VRAGEN\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stg.harmonyadjuvantmelanomastudy.com\\\/nl\\\/vragen-over-de-studiebehandeling\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/stg.harmonyadjuvantmelanomastudy.com\\\/nl\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stg.harmonyadjuvantmelanomastudy.com\\\/nl\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/stg.harmonyadjuvantmelanomastudy.com\\\/nl\\\/vragen-over-de-studiebehandeling\\\/#listItem\",\"name\":\"Vragen over de studiebehandeling\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/stg.harmonyadjuvantmelanomastudy.com\\\/nl\\\/vragen-over-de-studiebehandeling\\\/#listItem\",\"position\":2,\"name\":\"Vragen over de studiebehandeling\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/stg.harmonyadjuvantmelanomastudy.com\\\/nl\\\/#listItem\",\"name\":\"Home\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/stg.harmonyadjuvantmelanomastudy.com\\\/nl\\\/#organization\",\"name\":\"Harmony\",\"description\":\"Skin Cancer - Preventing Melanoma From Returning After Surgery\",\"url\":\"https:\\\/\\\/stg.harmonyadjuvantmelanomastudy.com\\\/nl\\\/\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stg.harmonyadjuvantmelanomastudy.com\\\/nl\\\/vragen-over-de-studiebehandeling\\\/#webpage\",\"url\":\"https:\\\/\\\/stg.harmonyadjuvantmelanomastudy.com\\\/nl\\\/vragen-over-de-studiebehandeling\\\/\",\"name\":\"The Harmony-Adjuvant Study Vragen over de studiebehandeling\",\"description\":\"De Harmony-Adjuvant-studie: VEELGESTELDE VRAGEN\",\"inLanguage\":\"nl-NL\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stg.harmonyadjuvantmelanomastudy.com\\\/nl\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stg.harmonyadjuvantmelanomastudy.com\\\/nl\\\/vragen-over-de-studiebehandeling\\\/#breadcrumblist\"},\"datePublished\":\"2022-04-12T21:47:23+00:00\",\"dateModified\":\"2023-02-13T19:17:39+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stg.harmonyadjuvantmelanomastudy.com\\\/nl\\\/#website\",\"url\":\"https:\\\/\\\/stg.harmonyadjuvantmelanomastudy.com\\\/nl\\\/\",\"name\":\"The Harmony Study:\",\"description\":\"Skin Cancer - Preventing Melanoma From Returning After Surgery\",\"inLanguage\":\"nl-NL\",\"publisher\":{\"@id\":\"https:\\\/\\\/stg.harmonyadjuvantmelanomastudy.com\\\/nl\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"The Harmony-Adjuvant Study Vragen over de studiebehandeling","description":"De Harmony-Adjuvant-studie: VEELGESTELDE VRAGEN","canonical_url":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/vragen-over-de-studiebehandeling\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/vragen-over-de-studiebehandeling\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/#listItem","position":1,"name":"Home","item":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/","nextItem":{"@type":"ListItem","@id":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/vragen-over-de-studiebehandeling\/#listItem","name":"Vragen over de studiebehandeling"}},{"@type":"ListItem","@id":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/vragen-over-de-studiebehandeling\/#listItem","position":2,"name":"Vragen over de studiebehandeling","previousItem":{"@type":"ListItem","@id":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/#listItem","name":"Home"}}]},{"@type":"Organization","@id":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/#organization","name":"Harmony","description":"Skin Cancer - Preventing Melanoma From Returning After Surgery","url":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/"},{"@type":"WebPage","@id":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/vragen-over-de-studiebehandeling\/#webpage","url":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/vragen-over-de-studiebehandeling\/","name":"The Harmony-Adjuvant Study Vragen over de studiebehandeling","description":"De Harmony-Adjuvant-studie: VEELGESTELDE VRAGEN","inLanguage":"nl-NL","isPartOf":{"@id":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/#website"},"breadcrumb":{"@id":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/vragen-over-de-studiebehandeling\/#breadcrumblist"},"datePublished":"2022-04-12T21:47:23+00:00","dateModified":"2023-02-13T19:17:39+00:00"},{"@type":"WebSite","@id":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/#website","url":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/","name":"The Harmony Study:","description":"Skin Cancer - Preventing Melanoma From Returning After Surgery","inLanguage":"nl-NL","publisher":{"@id":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/#organization"}}]},"og:locale":"nl_NL","og:site_name":"The Harmony-Adjuvant Study - Skin Cancer - Preventing Melanoma From Returning After Surgery","og:type":"article","og:title":"The Harmony-Adjuvant Study Vragen over de studiebehandeling","og:description":"De Harmony-Adjuvant-studie: VEELGESTELDE VRAGEN","og:url":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/vragen-over-de-studiebehandeling\/","article:published_time":"2022-04-12T21:47:23+00:00","article:modified_time":"2023-02-13T19:17:39+00:00","twitter:card":"summary_large_image","twitter:title":"The Harmony-Adjuvant Study Vragen over de studiebehandeling","twitter:description":"De Harmony-Adjuvant-studie: VEELGESTELDE VRAGEN"},"aioseo_meta_data":{"post_id":"114889","title":"#site_title #post_title","description":"De Harmony-Adjuvant-studie: VEELGESTELDE VRAGEN","keywords":[],"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":[],"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"limit_modified_date":false,"created":"2023-02-13 19:08:17","updated":"2023-02-13 19:31:57","ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tVragen over de studiebehandeling\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/"},{"label":"Vragen over de studiebehandeling","link":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/vragen-over-de-studiebehandeling\/"}],"_links":{"self":[{"href":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/wp-json\/wp\/v2\/pages\/114889","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/wp-json\/wp\/v2\/comments?post=114889"}],"version-history":[{"count":0,"href":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/wp-json\/wp\/v2\/pages\/114889\/revisions"}],"wp:attachment":[{"href":"https:\/\/stg.harmonyadjuvantmelanomastudy.com\/nl\/wp-json\/wp\/v2\/media?parent=114889"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}